
    
      The investigators conducted a prospective randomized controlled study in 165 patients
      American Society of Anesthesiologists (ASA) score I-III scheduled for primary TKA, divided in
      3 groups: group A (Etoricoxib 120 mg orally one hour before surgery), group B (Etoricoxib 120
      mg orally at the end of surgery) and group C placebo. Surgery has been performed under spinal
      anesthesia.

      All groups received postoperative analgesia when Numeric Rating Scale (NRS) over 3 with
      intravenous (IV) Perfalgan and morphine on demand for the following 48 h.

      The effectiveness was evaluated by the time from the initiation of spinal anesthesia until
      the first analgesic dose at NRS > 3, the total amount of morphine in the first 24 and 48
      hours postoperative, the side effects and necessary amount of adjuvant medication.
    
  